Is Reishi a Psychedelic Mushroom? The Evidence-Based Answer

Automated draft updated April 23, 2026

Editorial and clinical review are pending. This machine-generated derivative page is excluded from search indexing and must not be treated as a human-approved evidence review, medical recommendation, product claim, or complete safety assessment. Preserve the validation state shown on every linked ingredient or interaction record.

Reishi (Ganoderma lucidum) is not a psychedelic mushroom. It contains no psilocybin, psilocin, or any other hallucinogenic compound, and it does not alter perception or consciousness.

What Makes a Mushroom Psychedelic?

Psychedelic mushrooms — commonly called "magic mushrooms" — belong primarily to the genus Psilocybe and related species. Their psychoactive effects come from psilocybin, a compound the body converts to psilocin, which acts on serotonin (5-HT2A) receptors in the brain. Reishi contains none of these compounds. Its chemistry is categorically different: it is rich in polysaccharides, beta-D-glucans, and over 140 identified triterpenes, none of which are psychoactive.

What Reishi Actually Contains and Does

The pharmacologically active constituents of Ganoderma lucidum fall into two main classes:

Polysaccharides (beta-glucans): These high-molecular-weight carbohydrates bind to immune receptors such as Dectin-1 and TLR-2 on macrophages and dendritic cells, modulating innate immune signalling.
Ganoderic acids (triterpenes): Lanostane-type triterpenoids with demonstrated adaptogenic, anti-inflammatory, and mild sedative properties in preclinical models.

Neither class of compound crosses the blood-brain barrier in a way that produces hallucinations. The calming or sleep-supportive effects sometimes attributed to reishi are thought to arise from GABAergic modulation and adenosine activity — mechanisms more analogous to a mild herbal relaxant than to a psychedelic.

Chinese reishi, Siberian reishi, and Ganoderma sinense (Black Reishi) are closely related species with broadly similar phytochemical profiles and no psychoactive properties.

What the Research Shows

Clinical and preclinical evidence for reishi centres on three areas:

Immune modulation: A 2012 randomised controlled trial in cancer patients found that G. lucidum polysaccharide extract increased natural killer cell activity and reduced inflammatory cytokines compared to placebo.
Sleep quality: A 2012 mouse study published in the Journal of Pharmacological Sciences found that a water-soluble extract of G. lucidum reduced sleep latency and prolonged non-REM sleep time, effects attributed to adenosine, not psychoactive alkaloids.
Fatigue and stress: A 2005 pilot RCT in neurasthenia patients showed statistically significant reductions in fatigue scores after 8 weeks of supplementation versus placebo.

None of these mechanisms involve serotonin receptor agonism or any pathway associated with altered consciousness.

How Much Reishi Is Typically Used?

Most human studies have used standardised extracts providing:

Polysaccharide fraction: 1.5–3 g/day of a hot-water extract
Full-spectrum powder: 1–5 g/day of dried mushroom equivalent

Effects on sleep and immune markers generally emerge after 4–8 weeks of consistent use. Reishi is not acutely psychoactive at any studied dose.

Is Reishi Safe?

Reishi has a strong safety record when used in its traditional and studied forms. Reported side effects are uncommon and include mild digestive discomfort and, rarely, skin reactions with prolonged use. It is not recommended during pregnancy or alongside anticoagulant medications without medical supervision, due to mild platelet-inhibiting properties of some triterpenes. Importantly, there is no abuse potential, no tolerance mechanism, and no regulatory scheduling — in contrast to genuinely psychedelic fungi.

Practical Takeaway

If you are looking for evidence-based support for sleep, stress resilience, or immune function, reishi and lingzhi mushroom are well-studied options. If you encountered claims that reishi produces a "high" or vision-like states, those are not supported by pharmacological evidence or clinical data.

For a broader immune and adaptogenic approach, multi-mushroom formulas such as the PeakO2 6-mushroom blend combine reishi with complementary species like lion's mane and maitake.

---

Frequently asked questions

Does reishi contain psilocybin?

No. Reishi (Ganoderma lucidum) contains no psilocybin, psilocin, or related tryptamine compounds. Its active constituents are polysaccharides (beta-glucans) and triterpenes (ganoderic acids), neither of which are psychoactive.

Why do some people say reishi makes them feel calm or sleepy?

Reishi contains compounds that may mildly modulate GABAergic and adenosine pathways, which are associated with relaxation and sleep onset. This is a physiological, non-psychedelic effect — similar in mechanism to how certain herbal teas promote calm rather than altered perception.

What mushrooms are actually psychedelic?

Psychedelic mushrooms belong primarily to the genus Psilocybe (e.g., Psilocybe cubensis) and contain psilocybin, which the body metabolises into psilocin — a serotonin 5-HT2A receptor agonist. These are legally controlled substances in most countries and are entirely unrelated to functional mushrooms like reishi.

Can reishi be used alongside other functional mushrooms?

Yes. Reishi is commonly combined with lion's mane, maitake, and chaga in multi-mushroom formulas. These combinations are generally well-tolerated and are studied for additive immune-modulating and adaptogenic effects, with no psychoactive interactions.